Aarti Pharmalabs Ltd: Stock Analysis & Fundamentals

Updated this week

Aarti Pharmalabs Ltd (Pharma - API) — fundamental analysis, earnings data, and key metrics. PE: 25.6. ROE: 14.5%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

📊Debt increased 60% YoY — leverage rising

👔Promoter stake down 3.2% this quarter

🌐FII stake increased 0.6% this quarter

🏛️DII reducing — stake down 4.4%

Key Numbers

Current Price

₹609

Dividend Yield

0.82%

Market Cap

5.5K Cr

Valuation

N/A

Other Top Pharma - API Stocks Beating Nifty 500

Senores Pharmaceuticals Ltd

Average

+8.4%

Ind-Swift Laboratories Ltd

← Back to Pharma - API Dashboard

Frequently Asked Questions: Aarti Pharmalabs Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Aarti Pharmalabs Ltd's latest quarterly results?

Aarti Pharmalabs Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: -35.1%
Revenue Growth YoY: -19.7%
Operating Margin: 24.0%

What is Aarti Pharmalabs Ltd's current PE ratio?

Aarti Pharmalabs Ltd's current PE ratio is 25.6x.

Current PE: 25.6x
Market Cap: 5.5K Cr
Dividend Yield: 0.82%

What is Aarti Pharmalabs Ltd's price-to-book ratio?

Aarti Pharmalabs Ltd's price-to-book ratio is 2.7x.

Price-to-Book (P/B): 2.7x
Book Value per Share: ₹226
Current Price: ₹609

Is Aarti Pharmalabs Ltd a fundamentally strong company?

Aarti Pharmalabs Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 17.0%

Is Aarti Pharmalabs Ltd debt free?

Aarti Pharmalabs Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹659 Cr

What is Aarti Pharmalabs Ltd's return on equity (ROE) and ROCE?

Aarti Pharmalabs Ltd's return ratios over recent years

FY2023: ROCE 16.0%
FY2024: ROCE 17.0%
FY2025: ROCE 17.0%

Is Aarti Pharmalabs Ltd's cash flow positive?

Aarti Pharmalabs Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹332 Cr
Free Cash Flow (FCF): ₹-82 Cr
CFO/PAT Ratio: 122% (strong cash conversion)

What is Aarti Pharmalabs Ltd's dividend yield?

Aarti Pharmalabs Ltd's current dividend yield is 0.82%.

Dividend Yield: 0.82%
Current Price: ₹609

Who holds Aarti Pharmalabs Ltd shares — promoters, FII, DII?

Aarti Pharmalabs Ltd's shareholding pattern (Dec 2025)

Promoters: 43.1%
FII (Foreign): 7.7%
DII (Domestic): 7.7%
Public: 41.5%

Is promoter holding increasing or decreasing in Aarti Pharmalabs Ltd?

Aarti Pharmalabs Ltd's promoter holding has increased recently.

Current Promoter Holding: 43.1% (Dec 2025)
Previous Quarter: 42.9% (Sep 2025)
Change: +0.22% (increasing — positive signal)

Is Aarti Pharmalabs Ltd a new momentum entry or an established outperformer?

Aarti Pharmalabs Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Aarti Pharmalabs Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Aarti Pharmalabs Ltd may be worth studying

Cash flow is positive — CFO ₹332 Cr

What is the investment thesis for Aarti Pharmalabs Ltd?

Aarti Pharmalabs Ltd investment thesis summary:

What is the future outlook for Aarti Pharmalabs Ltd?

Aarti Pharmalabs Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.